CH460766A - Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden - Google Patents

Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden

Info

Publication number
CH460766A
CH460766A CH1351964A CH1351964A CH460766A CH 460766 A CH460766 A CH 460766A CH 1351964 A CH1351964 A CH 1351964A CH 1351964 A CH1351964 A CH 1351964A CH 460766 A CH460766 A CH 460766A
Authority
CH
Switzerland
Prior art keywords
alkylidene
steroids
preparation
Prior art date
Application number
CH1351964A
Other languages
English (en)
Inventor
Pieter Van Vliet Nicolaas
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of CH460766A publication Critical patent/CH460766A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1351964A 1963-10-23 1964-10-19 Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden CH460766A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL299654 1963-10-23

Publications (1)

Publication Number Publication Date
CH460766A true CH460766A (de) 1968-08-15

Family

ID=19755156

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1351964A CH460766A (de) 1963-10-23 1964-10-19 Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden

Country Status (10)

Country Link
US (1) US3301880A (de)
BE (1) BE654772A (de)
BR (1) BR6463664D0 (de)
CH (1) CH460766A (de)
DE (1) DE1468422C3 (de)
DK (1) DK117632B (de)
FR (1) FR1453813A (de)
GB (1) GB1085035A (de)
NL (1) NL299654A (de)
SE (1) SE329155B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3414564A (en) * 1966-03-03 1968-12-03 Hoffmann La Roche Process for the production of 17-ethylidene steroids
US3501508A (en) * 1967-01-12 1970-03-17 Ortho Pharma Corp Steroidal adamantates
US3997664A (en) * 1971-02-09 1976-12-14 Sandoz, Inc. Substituted carbinol derivatives
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
TWI265167B (en) * 1999-11-29 2006-11-01 Akzo Nobel Nv 3-methylene steroid derivatives

Also Published As

Publication number Publication date
SE329155B (de) 1970-10-05
NL299654A (de)
BE654772A (de)
US3301880A (en) 1967-01-31
DE1468422C3 (de) 1974-04-11
FR1453813A (fr) 1966-07-22
DK117632B (da) 1970-05-19
BR6463664D0 (pt) 1973-08-07
GB1085035A (en) 1967-09-27
DE1468422B2 (de) 1973-09-06
DE1468422A1 (de) 1969-01-09

Similar Documents

Publication Publication Date Title
CH468966A (de) Verfahren zur Herstellung von 3-Aminotricyclo-(4,3,1,1,3,8)-undecan
CH459196A (de) Verfahren zur Herstellung von 4,6-Pregnadienderivaten
CH437316A (de) Verfahren zur Herstellung von substituierten Phenyl-amino-1,3-diazacyclopenten-(2)-Verbindungen
CH458587A (de) Verfahren zur Herstellung von 8,9,10,11-Tetrahydro-12-phthaloperinon
CH460766A (de) Verfahren zur Herstellung von 3,3-Alkyliden-19-nor-steroiden
CH479574A (de) Verfahren zur Herstellung von 13-Jod-14-oxo 13,14-seco-steroiden
CH436317A (de) Verfahren zur Herstellung von 5-Joduracil-2'-desoxyribosid-3',5'-di-Estern
CH449610A (de) Verfahren zur Herstellung von Oestra-4,9-dien-3-olen
AT247866B (de) Verfahren zur Herstellung von 2, 6-Dichlorbenzonitril
CH446312A (de) Verfahren zur Herstellung von cis,cis-Cyclodecadien-(1,6)
AT244334B (de) Verfahren zur Herstellung von neuen 2, 1-Benzisothiazolen
CH437320A (de) Verfahren zur Herstellung von 4-Amino-5-hydroxypyridazonen (6)
CH451163A (de) Verfahren zur Herstellung von 2,2-Bipyridylium-dihalogeniden
CH445477A (de) Verfahren zur Herstellung von 1-Hydroxy-2,2,6,6-tetrachlorcyclohexankarbonamid-1
CH441352A (de) Verfahren zur Herstellung von 1-Phenyl-3-butyl-4-methyl-triazolon-(5)
CH459242A (de) Verfahren zur Herstellung von 1,2-Dihydro-1-hydroxy-1,3,5-triazinen
AT247848B (de) Verfahren zur Herstellung von 1, 3-Dioxo-2-alkylcyclopentanen
CH441583A (de) Verfahren zur Herstellung von 1,4-Diarylamino-5-nitro-8-hydroxy-anthrachinonen
CH439328A (de) Verfahren zur Herstellung von 3,5-Dijodthyroninen
CH435245A (de) Verfahren zur Herstellung von 1-Aryl-perchlor-2-aza-alkenen-(2)
CH427830A (de) Verfahren zur Herstellung von substituierten 1,4-Benzodiazepinen
CH444154A (de) Verfahren zur Herstellung von 1(10),2,4a(5)-A-Homoöstratrien-4-onderivaten
AT253703B (de) Verfahren zur Herstellung von 3, 6-Dioxo-A-nor-B-homo-steroiden
CH451151A (de) Verfahren zur Herstellung von 1,4-Benzoxazin-2-onen
CH464174A (de) Verfahren zur Herstellung von 2,6-Dichlor-4-nitrobenzamid